EUVIMEDEUVIMED entdecken
Crossref

Prophylactic Administration of Gut Microbiome Metabolites Abrogated Microglial Activation and Subsequent Neuroinflammation in an Experimental Model of Japanese Encephalitis

Indira Priya Siva Venkatesh, Atreye Majumdar iD, Anirban Basu iD

ACS Chemical Neuroscience · 2024

DOI: 10.1021/acschemneuro.4c00028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2024. Verfasst von Indira Priya Siva Venkatesh und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Brain Research Centre, Manesar, Haryana 122052, India. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Neuroinflammatory Diseases, Encephalitis, Japanese, Fatty Acids, Volatile. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Science and Engineering Research Board, National Brain Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Short-chain fatty acids (SCFAs) are gut microbial metabolic derivatives produced during the fermentation of ingested complex carbohydrates. SCFAs have been widely regarded to have a potent anti-inflammatory and neuro-protective role and have implications in several disease conditions, such as, inflammatory bowel disease, type-2 diabetes, and neurodegenerative disorders. Japanese encephalitis virus (JEV), a neurotropic flavivirus, is associated with life threatening neuro-inflammation and neurological sequelae in infected hosts. In this study, we hypothesize that SCFAs have potential in mitigating JEV pathogenesis. Postnatal day 10 BALB/c mice were intraperitoneally injected with either a SCFA mixture (acetate, propionate, and butyrate) or PBS for a period of 7 days, followed by JEV infection. All mice were observed for onset and progression of symptoms. The brain tissue was collected upon reaching terminal illness for further analysis. SCFA-supplemented JEV-infected mice (SCFA + JEV) showed a delayed onset of symptoms, lower hindlimb clasping score, and decreased weight loss and increased survival by 3 days (p < 0.0001) upon infection as opposed to the PBS-treated JEV-infected animals (JEV). Significant downregulation of inflammatory cytokines TNF-α, MCP-1, IL-6, and IFN-Υ in the SCFA + JEV group relative to the JEV-infected control group was observed. Inflammatory mediators, phospho-NF-kB (P-NF-kB) and iba1, showed 2.08 ± 0.1 and 3.132 ± 0.43-fold upregulation in JEV versus 1.19 ± 0.11 and 1.31 ± 0.11-fold in the SCFA + JEV group, respectively. Tissue section analysis exhibited reduced glial activation (JEV group─42 ± 2.15 microglia/ROI; SCFA + JEV group─27.07 ± 1.8 microglia/ROI) in animals that received SCFA supplementation prior to infection as seen from the astrocytic and microglial morphometric analysis. Caspase-3 immunoblotting showed 4.08 ± 1.3-fold upregulation in JEV as compared to 1.03 ± 0.14-fold in the SCFA + JEV group and TUNEL assay showed a reduced cellular death post-JEV infection (JEV-6.4 ± 1.5 cells/ROI and SCFA + JEV-3.7 ± 0.73 cells/ROI). Our study critically contributes to the increasing evidence in support of SCFAs as an anti-inflammatory and neuro-protective agent, we further expand its scope as a potential supplementary intervention in JEV-mediated neuroinflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeNeuroinflammatory DiseasesEncephalitis, JapaneseFatty Acids, VolatileMicrogliaEncephalitis Viruses, JapaneseSurvival AnalysisChemokinesInflammation MediatorsCytokine Release SyndromeHumansFemaleAnimalsMiceApoptosisBrainViral LoadTime Factors

Stichwörter der Autor:innen

Japanese encephalitisanti-inflammatorycytokineneuroinflammationshort chain fatty acids

Substanzen

Fatty Acids, VolatileChemokinesInflammation Mediators

Autor:innen und Institutionen

  • National Brain Research Centre, Manesar, Haryana 122052, India.

ORCID-Profile: Atreye Majumdar, Anirban Basu

Förderung

  • Science and Engineering Research Board
  • National Brain Research Centre

Zitieren

APA

Siva Venkatesh, I. P., Majumdar, A., & Basu, A. (2024). Prophylactic Administration of Gut Microbiome Metabolites Abrogated Microglial Activation and Subsequent Neuroinflammation in an Experimental Model of Japanese Encephalitis. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00028

Vancouver

Siva Venkatesh IP, Majumdar A, Basu A. Prophylactic Administration of Gut Microbiome Metabolites Abrogated Microglial Activation and Subsequent Neuroinflammation in an Experimental Model of Japanese Encephalitis. ACS Chemical Neuroscience. 2024. doi:10.1021/acschemneuro.4c00028

BibTeX
@article{SivaVenkatesh2024,
  author = {Siva Venkatesh, Indira Priya and Majumdar, Atreye and Basu, Anirban},
  title = {Prophylactic Administration of Gut Microbiome Metabolites Abrogated Microglial Activation and Subsequent Neuroinflammation in an Experimental Model of Japanese Encephalitis},
  journal = {ACS Chemical Neuroscience},
  year = {2024},
  doi = {10.1021/acschemneuro.4c00028}
}
Kostenlos starten →